348-66-3

Basic information

• Product Name: D-ornithine
• Synonyms: (2R)-2,5-diaminopentanoic acid;CPD-217
• CAS NO: 348-66-3
• Molecular Formula: C₅H₁₂N₂O₂
• Molecular Weight: 133.17042
• EINECS: 206-482-0
• Mol File: 348-66-3.mol
• Article Data: 26

Chemical Properties

• Melting Point: 140 °C
• Boiling Point: 308.7±32.0 °C(Predicted)
• Appearance: /
• Density: 1.165±0.06 g/cm3(Predicted)
• PKA: 2.45±0.24(Predicted)
• CAS DataBase Reference: D-ornithine(CAS DataBase Reference)
• NIST Chemistry Reference: D-ornithine(348-66-3)
• EPA Substance Registry System: D-ornithine(348-66-3)

Safety Data

• Hazardous Substances Data: 348-66-3(Hazardous Substances Data)

Usage

Definition

ChEBI: The D-enantiomer of ornithine. It is an intermediate metabolite produced in the urea cycle.

Upstream product

• 70-26-8 D-ornithine 
• 542-32-5 (R,S)-2-aminoadipic acid 
• 15920-89-5 N^α-carbamoyl-L-arginine 
• 7438-77-9 Orn-δ-NOH 
• 2149-70-4 N-nitro-L-arginine 
• 7647-01-0 hydrogenchloride 
• 495-46-5 di(benzoyl)-L-(+)-ornithine 
• 74-79-3 L-arginine 
• 69980-44-5 N⁵-benzoyl-DL-ornithine 
• 1174277-72-5 (3R,9R)-2,8-dioxo-1,7-diazacyclododecane-3,9-diamine 
• 132465-72-6 N²-(toluene-4-sulfonyl)-D-glutamine methyl ester 
• 42749-49-5 N²-(toluene-4-sulfonyl)-D-glutamine 
• 100616-51-1 N-(toluene-4-sulfonyl)-D-glutamic acid-1-methyl ester-5-nitrile 
• 145876-67-1 N²,N⁵-bis-(furan-2-carbonyl)-ornithine 

Downstream Products

• 5058-01-5 3-hydroxytetrahydro-2H-pyran-2-one 
• 2000-59-1 5-amino-2-oxo-valeric acid 
• 110-60-1 1,4-diaminobutane 
• 74-79-3 L-arginine 
• 70-26-8 2,5-diaminopentanoic acid 
• 13594-51-9 D-citrulline 
• 5724-81-2 1-pyrroline 
• 2640-58-6 N²-benzyloxycarbonyl-L-ornithine 
• 2274-58-0 N,N'-di(benzyloxycarbonyl)-D-ornithine 
• 113737-73-8 D-Ornithyl-L-methionyl-L-aspartyl-L-phenylalanine amide hydrochloride 
• 439152-10-0 N²,N⁵-bis(2,3-diacetoxybenzoyl)-D-ornithine 
• 2139-03-9 Δ¹-pyrroline-2-carboxylic acid 
• 88763-76-2 (R)-(+)-3-Amino-2-piperidinon 
• 156706-47-7 N^G-monomethyl-L-arginine hydrochloride 

Relevant articles and documents

Catenulobactins A and B, Heterocyclic Peptides from Culturing Catenuloplanes sp. with a Mycolic Acid-Containing Bacterium

The production of two new heterocyclic peptide isomers, catenulobactins A (1) and B (2), in cultures of Catenuloplanes sp. RD067331 was significantly increased when it was cocultured with a mycolic acid-containing bacterium. The planar structures and absolute configurations of the catenulobactins were determined based on NMR/MS and chiral-phase GC-MS analyses. Catenulobactin B (2) displayed Fe(III)-chelating activity and moderate cytotoxicity against P388 murine leukemia cells.

FUNCTIONALIZED FLUORINE CONTAINING PHTHALOCYANINE MOLECULES

Functionalized fluorine containing phthalocyanine molecules, methods of making, and methods of use in diagnostic applications and disease treatment are disclosed herein. In some embodiments, the fluorine containing phthalocyanine molecules are functionalized with a reactive functional group or at least one cancer-targeting ligand (CTL). The CTL can facilitate more efficient binding and/or internalization to a cancer cell than to a healthy cell. The CTL can inhibit expression of oncoprotein in some embodiments. The pthalocyanine moiety can be used in diagnostic applications, such as fluorescence labeling of a cancer cell, and/or treatment applications, such as catalyzing formation of a reactive oxygen species (ROS) which can contribute to cell death of a cancer cell.

GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA

The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to cell in vivo. The pharmacokinetic modulator improve in vivo targeting compared to the targeting ligand alone. Targeting ligand-pharmacokinetic modulator targeting moiety targeted RNAi polynucleotides can be administered in vivo alone or together with co-targeted delivery polymers.